» Articles » PMID: 27242671

Fecal Carriage of Staphylococcus Aureus in the Hospital and Community Setting: A Systematic Review

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2016 Jun 1
PMID 27242671
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Rationale: Staphylococcus aureus fecal carriage has been identified as a potential source for nosocomial transmission and a risk factor for disease development. This systematic review determined the overall S. aureus [including methicillin susceptible and resistant S. aureus (MSSA and MRSA)] fecal carriage rates within the community and healthcare settings.

Methodology: Peer-reviewed articles indexed in Medline, Scopus, Academic Search Premier, Africa-Wide Information, CINAHL, and Web of Science were identified using applicable and controlled vocabulary through to 11 November 2015. Eligible studies were ascertained by three independent reviewers. Random-effects meta-analyses of proportions were performed to determine S. aureus, MSSA and MRSA fecal carriage rates reported by eligible studies.

Results: Twenty six studies were included in this review. The pooled estimates for S. aureus, MSSA and MRSA fecal carriage were 26% (95% confidence interval (CI): 16.8-36.3%), 86% (95% confidence interval (CI): 65.9-97.9%) and 10% (95% CI: 0.7-27.0%), respectively. Fecal S. aureus carriage rates increased on average from 10 to 65% during the first 8 weeks of life, followed by an average carriage rate of 64% at 6 months and 46% at 1 year of life. Genotyping techniques were employed mainly in studies conducted in developed countries and comprised largely of gel-based techniques. Six studies reported on the role of S. aureus fecal strains in diarrhea (n = 2) and the risk for acquiring infections (n = 4). Eight of the 26 studies included in this review performed antibiotic susceptibility testing of S. aureus fecal isolates.

Conclusion: This study provides evidence that screening for S. aureus fecal carriage, at least in populations at high risk, could be an effective measure for the prevention of S. aureus transmission and infection in the healthcare and community setting. More well-structured studies need to be conducted and sequence-based genotyping techniques should be employed for the comparison of isolates on a global scale in both developing and developed countries.

Citing Articles

Hinokitiol potentiates antimicrobial activity of bismuth drugs: a combination therapy for overcoming antimicrobial resistance.

Ip T, Wang Y, Wang S, Pu K, Wang R, Han B RSC Med Chem. 2025; .

PMID: 40027343 PMC: 11865920. DOI: 10.1039/d4md00860j.


Development and Validation of the MAST ISOPLEX Kit for Simultaneous Detection of Shiga Toxin/Verotoxin 1 and 2 () with Inhibition Control (IC) in a Rapid Loop-Mediated Isothermal Amplification (LAMP) Multiplex Assay.

Suwara M, Bennett M, Voto I, Brownlie C, Gillies E Int J Mol Sci. 2024; 25(18).

PMID: 39337553 PMC: 11432264. DOI: 10.3390/ijms251810067.


Microbiota Profiling on Veterinary Faculty Restroom Surfaces and Source Tracking.

Jabri H, Krings S, Fall P, Baurain D, Daube G, Taminiau B Microorganisms. 2023; 11(8).

PMID: 37630613 PMC: 10459056. DOI: 10.3390/microorganisms11082053.


FadB is a dehydrogenase that mediates cholate resistance and survival under human colonic conditions.

Alsultan A, Walton G, Andrews S, Clarke S Microbiology (Reading). 2023; 169(3).

PMID: 36947574 PMC: 10191381. DOI: 10.1099/mic.0.001314.


Non-deacetylated poly--acetylglucosamine-hyperproducing undergoes immediate autoaggregation upon vortexing.

Kutsuno S, Hayashi I, Yu L, Yamada S, Hisatsune J, Sugai M Front Microbiol. 2023; 13:1101545.

PMID: 36699608 PMC: 9868172. DOI: 10.3389/fmicb.2022.1101545.


References
1.
Mertz D, Frei R, Jaussi B, Tietz A, Stebler C, Fluckiger U . Throat swabs are necessary to reliably detect carriers of Staphylococcus aureus. Clin Infect Dis. 2007; 45(4):475-7. DOI: 10.1086/520016. View

2.
Acton D, Plat-Sinnige M, van Wamel W, De Groot N, van Belkum A . Intestinal carriage of Staphylococcus aureus: how does its frequency compare with that of nasal carriage and what is its clinical impact?. Eur J Clin Microbiol Infect Dis. 2008; 28(2):115-27. DOI: 10.1007/s10096-008-0602-7. View

3.
Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med. 2011; 3(3):e123-30. PMC: 3090117. View

4.
Tong S, Davis J, Eichenberger E, Holland T, Fowler Jr V . Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015; 28(3):603-61. PMC: 4451395. DOI: 10.1128/CMR.00134-14. View

5.
Shehabi A, Abu-Yousef R, Badran E, Al-Bakri A, Abu-Qatouseh L, Becker K . Major characteristics of Staphylococcus aureus colonizing Jordanian infants. Pediatr Int. 2013; 55(3):300-4. DOI: 10.1111/ped.12060. View